Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Greenberg

Showing results (371-380 of 405) with videos related to

Pageof 41
Sort By:
JAMA|June 22, 1994
A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile diseaseL V McFarland, C M Surawicz, R N Greenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patientsP J Cagnoni, T J Walsh, M M Prendergast, et al.
American Journal of Physiology. Cell Physiology|July 11, 2006
Nucleoside reverse transcriptase inhibitors prevent HIV protease inhibitor-induced atherosclerosis by ubiquitination and degradation of protein kinase CEmily L Bradshaw, Xiang-An Li, Theresa Guerin, et al.
The Journal of Clinical Investigation|February 6, 2003
HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophagesJames Dressman, Jeanie Kincer, Sergey V Matveev, et al.
The Lancet. Infectious Diseases|February 2, 2013
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 studyMarc Gurwith, Michael Lock, Eve M Taylor, et al.
Human Vaccines & Immunotherapeutics|August 22, 2024
Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccineRichard N Greenberg, Darja Schmidt, Daniela Reichhardt, et al.
Medicine|January 1, 2014
Histoplasmosis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): multicenter study of outcomes and factors associated with relapseThein Myint, Albert M Anderson, Alejandro Sanchez, et al.
Pilot and Feasibility Studies|October 14, 2023
Reconsolidation of traumatic memories protocol compared to trauma-focussed cognitive behaviour therapy for post-traumatic stress disorder in UK military veterans: a randomised controlled feasibility trialJ Sturt, R Rogers, C Armour, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|November 24, 1999
Renal effects of uroguanylin and guanylin in vivoS L Carrithers, M J Hill, B R Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2003
Voriconazole treatment for less-common, emerging, or refractory fungal infectionsJohn R Perfect, Kieren A Marr, Thomas J Walsh, et al.
Pageof 41

Showing results (371-380 of 405) with videos related to

Sort By:
Pageof 41
JAMA|June 22, 1994
A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile diseaseL V McFarland, C M Surawicz, R N Greenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patientsP J Cagnoni, T J Walsh, M M Prendergast, et al.
American Journal of Physiology. Cell Physiology|July 11, 2006
Nucleoside reverse transcriptase inhibitors prevent HIV protease inhibitor-induced atherosclerosis by ubiquitination and degradation of protein kinase CEmily L Bradshaw, Xiang-An Li, Theresa Guerin, et al.
The Journal of Clinical Investigation|February 6, 2003
HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophagesJames Dressman, Jeanie Kincer, Sergey V Matveev, et al.
The Lancet. Infectious Diseases|February 2, 2013
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 studyMarc Gurwith, Michael Lock, Eve M Taylor, et al.
Human Vaccines & Immunotherapeutics|August 22, 2024
Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccineRichard N Greenberg, Darja Schmidt, Daniela Reichhardt, et al.
Medicine|January 1, 2014
Histoplasmosis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): multicenter study of outcomes and factors associated with relapseThein Myint, Albert M Anderson, Alejandro Sanchez, et al.
Pilot and Feasibility Studies|October 14, 2023
Reconsolidation of traumatic memories protocol compared to trauma-focussed cognitive behaviour therapy for post-traumatic stress disorder in UK military veterans: a randomised controlled feasibility trialJ Sturt, R Rogers, C Armour, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|November 24, 1999
Renal effects of uroguanylin and guanylin in vivoS L Carrithers, M J Hill, B R Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2003
Voriconazole treatment for less-common, emerging, or refractory fungal infectionsJohn R Perfect, Kieren A Marr, Thomas J Walsh, et al.
Pageof 41